Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 467,000 | 331,000 | 7,000 | 25,000 | 7,000 |
| Receivables | 206,000 | 193,000 | 185,000 | 290,000 | 290,000 |
| Inventories | 48,000 | 41,000 | 36,000 | 34,000 | 32,000 |
| TOTAL | $721,000 | $565,000 | $228,000 | $349,000 | $329,000 |
| Non-Current Assets | |||||
| PPE Net | 32,000 | 13,000 | 13,000 | 13,000 | 11,000 |
| Intangibles | 62,000 | 91,000 | 94,000 | 117,000 | 135,000 |
| Other Non-Current Assets | 122,000 | 78,000 | 91,000 | 78,000 | 84,000 |
| TOTAL | $216,000 | $182,000 | $198,000 | $208,000 | $230,000 |
| Total Assets | $937,000 | $747,000 | $426,000 | $557,000 | $559,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 34,000 | 17,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 528,000 | 383,000 | 434,000 | 103,000 | 105,000 |
| Other current liabilities | N/A | N/A | N/A | 293,000 | 200,000 |
| TOTAL | $603,000 | $462,000 | $451,000 | $396,000 | $305,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 571,000 | 719,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 42,000 | 41,000 | 41,000 | 16,000 | 0 |
| TOTAL | $613,000 | $760,000 | $41,000 | $16,000 | $N/A |
| Total Liabilities | $1,216,000 | $1,222,000 | $492,000 | $412,000 | $305,000 |
| Shareholders' Equity | |||||
| Common Shares | 72,000 | 1,437,000 | 1,437,000 | N/A | N/A |
| Retained earnings | 967,000 | -601,000 | -208,000 | N/A | N/A |
| Other shareholders' equity | -1,318,000 | -1,311,000 | -1,295,000 | 145,000 | 254,000 |
| TOTAL | $-279,000 | $-475,000 | $-66,000 | $145,000 | $254,000 |
| Total Liabilities And Equity | $937,000 | $747,000 | $426,000 | $557,000 | $559,000 |